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Background: Given the associated morbidity, mortality, and ﬁnancial consequences of catheter associated
urinary tract infections (CAUTIs), efforts should be made to mitigate the risk. We sought to describe, and
report results for a post-catheter removal bladder management protocol focused on decreasing catheter reinsertion, catheter days, and overall CAUTI risk.
Methods: This was a quality improvement initiative implemented over a 3-month period at a single urban,
tertiary health care center. Patients with an indwelling urinary catheter deemed eligible for removal were
followed and cared for according to the study protocol. Rates of catheter reinsertion, catheter days, and
assessment of CAUTI risk were compared between cohorts.
Results: A total of 173 patients were eligible for protocol enrollment. Catheter reinsertion rate was 16% during the pilot, compared to 21% and 27% for the historical cohorts, (P = .02). The mean number of catheter
day’s during the study was 1.4 days, compared to 9.5 and 5.6 days in the historical cohorts (P = .004). Catheter
hours (OR 1.010 95% CI 1.005 − 1.015 P < .0001.) was a predictor of catheter reinsertion during the pilot.
Conclusions: Our protocol resulted in a reduction of catheter reinsertion rates and number of catheter days.
Expansion of this protocol to a larger patient cohort is required
© 2021 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All
rights reserved.

INTRODUCTION
Urinary tract infections (UTI) account for approximately 40% of
hospital-acquired infections (HAI) in the United States, with a vast
majority occurring in patients with an indwelling urinary catheter
(IUC).1,2 It is estimated that 25%-45% of adult patients will have an
IUC inserted at some point during their hospitalization, with rates
as high as 89% for patients within the ICU.3-7 Moreover, up to 50% of
continued IUC have been found to be unnecessary.3 Up to 68% of
patients undergoing major surgery have a perioperative IUC, of
which 50% are inserted for 2 or more days.8 With each additional
day the catheter remains in place, there is an estimated 3%-7%
increased risk of acquiring bacteriuria.4 Consequently, catheter-associated urinary tract infection (CAUTI) is one of the most commonly
reported HAI.4

* Address correspondence to Ali A. Dabaja, MD, Vattikuti Urology Institute, Henry
Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202
E-mail address: adabaja2@hfhs.org (A.A. Dabaja).
Conﬂict of Interest: No conﬂict of interest to report for any author.

CAUTIs are associated with higher morbidity and mortality, prolonged hospital stay, and increased healthcare costs.9-11 CAUTIs may
result in progressive ascending UTI and pyelonephritis and bacteremia.2 CAUTIs have been noted to prolong a patient’s average length of
stay up to 2 additional days.12,13 It is estimated that CAUTIs add an
additional cost of $4,700 to $29,700 USD per admission, which equates
to $115 million to $1.82 billion USD spent annually on these preventable infections.14,15 It has also been estimated that approximately
13,000 deaths could be attributed to CAUTIs annually.16 According to
current evidence-based strategies, 65%-70% of reported CAUTIs may be
preventable, therefore making CAUTI the most preventable HAI.14
Additionally, non−infectious complications of IUC include gross hematuria, urethral strictures or erosion, and immobility leading to falls,
pressure ulcers and venous thromboembolism.3
Given the implications of IUC and CAUTI, extensive efforts have
focused on prevention. In 2008, the Center for Medicare & Medicaid
(CMS) implemented a non−payment policy for patients who develop
CAUTIs, further intensifying and incentivizing efforts to prevent these
infections. The Center for Disease Control and Prevention (CDC) has
partnered with Health Research & Educational Trust (HRET) to

https://doi.org/10.1016/j.ajic.2021.06.019
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develop a tiered approach for the prevention of CAUTI.3 Studies have
demonstrated that CAUTI rates can be reduced by implementing
guidelines or using catheter bundles focused on insertion of IUC for
appropriate indications, aseptic technique, proper maintenance,
prompt removal of unnecessary IUC, and urine culture stewardship.4,17-21 Despite the immense work that has been conducted,
CAUTI remains a signiﬁcant healthcare concern.
The objective of this study is to evaluate the impact of a post-catheter removal bladder management protocol referred to as the Urinary
Catheter Alleviation Navigator Protocol (UCANP) on IUC reinsertion,
IUC days, and overall CAUTI rate.

METHODS
Study design, setting and population
This was a prospective quality improvement initiative executed at
an urban, 887-bed tertiary health care center from January 6, 2020 to
March 13, 2020. The protocol was piloted in 4 neurosurgical and neurologic units that were preselected by the investigators due to the
high incidence of urinary retention and UTI in these areas.22, 23 The 4
participating units comprised of 1 neuro-intensive care unit, 2 neurosurgical and/or neurologic step-down units, and 1 neurosurgical and/
or neurologic general practice unit (GPU).
Study cohort included all patients admitted or transferred to one
of the participating units with an existing or newly inserted IUC that
was subsequently removed in the pilot units. Patients transferred
from a participating unit to a non−participating unit with an IUC
were excluded from the study.

The study cohort was compared to 2 other matched historical
cohorts from the same medical units who met the same IUC criteria.
The 2019 cohort was from January 6, 2019 to March 13, 2019, and
the pre-pilot cohort was from October 31, 2019 to January 5, 2020.
Patients within the historical cohorts were managed according to
previously established practice patterns.
Protocol overview
Patients with IUC who were medically eligible for removal of the
IUC were followed and cared for according to the study protocol
(Fig 1). In summary, patients were monitored for spontaneous voiding following removal of the IUC. A post-void residual (PVR) was
obtained if a spontaneous void occurred within the ﬁrst 4 hours.
Patients with a PVR ≤ 100 mLgraduated from the post-catheter
removal management protocol, and urine output was monitored at
the discretion of the primary medical team. Patients with a PVR ≥
400 mL were initiated on the intermittent catherization (IC) pathway,
which involved IC by nursing staff. The protocol was restarted with
close monitoring every 4 hours. Patients with a PVR between 100
and 400 mL were monitored with repeat bladder scans every 4 hours
and followed the protocol suggested pathway depending on the
repeat bladder scan volumes. Those who did not spontaneously void
within 4 hours or had a PVR ≥ 400 mL were started on the IC pathway. The IC pathway involved nurse conducted IC rather than
replacement of the Foley catheter. Following the initial IC, nurses
would repeat the aforementioned pathway. Patients would undergo
nurse conducted IC for 48 hours following removal of the IUC. If they
were unable to void spontaneously by that time, the patient would
be evaluated by medical personnel to determine the patient’s

Fig 1. Protocol pathway.* If the patient develops symptoms, including but not limited to suprapubic fullness, suprapubic tenderness or inability to void, promptly obtain bladder
scan. Intermittent catheterization is to be performed if medically necessary. y Continue the above protocol for 48 hours following removal of the indwelling urinary catheter (IUC). If
patient unable to spontaneously void with acceptable post void residuals, the patient is evaluated by the primary medical team to assess overall cognitive and physical ability, familial support and reimbursement for catheters and catheter related supplies to determine safety, and eligibility of continued intermittent catheterization. Outpatient urological evaluation is scheduled prior to discharge.
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cognitive and physical ability, family support status, post-discharge
location (home vs skilled nursing center, long term acute care center,
sub-acute rehab center etc.), and ability to continue self or careassisted IC after discharge. This evaluation was performed on an individual basis by the primary medical team, which included physicians,
and nurses.
To enhance compliance with the outlined protocol, all medical
personnel (physicians, nurses, nursing assistants) were provided educational material and instructions on the outlined protocol. Debriefings were held every 3 weeks by nurse leadership and the CAUTI
Comprehensive Unit-Based Safety Program (CUSP) Champions. All
patients who were deemed eligible for the study protocol had an
order placed into the electronic medical record (EMR) by the treating
physician to aid in tracking and compliance. This order provided
nursing staff with timely reminders and instructions regarding the
next appropriate steps in the protocol. All bladder scan volumes,
number of ICs performed, and IUC reinsertions were documented in
the EMR. The data were collected prospectively and analyzed.
Measured outcomes
The primary objective of the present study was to compare the
rates of IUC reinsertions and number of IUC day’s during the study
period to historical cohorts in the same units. The number of CAUTIs
were also monitored and identiﬁed based on the deﬁnition established by the Center for Disease Control and Prevention (CDC)
National Healthcare Safety Network (NHSN). “Catheter days” was
deﬁned according to the CDC-NHSN.3 Root cause analysis and veriﬁcation were performed on all potential CAUTIs by the Infection Prevention and Control team. Secondary objectives included analysis of
factors which could potentially predict catheter reinsertion. All data
points were compared to the historical cohorts.
Statistical analysis
Descriptive analysis was performed. Mean and standard deviations were reported as continuous variables, while frequency counts
and percentages were displayed as categorical variables. Comparisons for categorical variables between the 3 time periods were performed using x2Tests. Fisher’s Exact Test was used when expected
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cell counts were <5. ANOVA was used for comparisons of normally
distributed continuous variables between the 3 time periods. Kruskal-Wallis tests were used for comparisons of non−normally distributed continuous variables.
Univariable logistic regression was used at each time period to
assess whether select individual variables were statistically signiﬁcant predictors of IUC reinsertion without controlling for other variables. Using a backward selection process, multivariable logistic
regression was performed using numerous variables to predict IUC
reinsertion for each time period. Statistical signiﬁcance was determined if P < .05. All analyses were performed using SAS 9.4 (SAS
Institute Inc, Cary, NC, USA).
RESULTS
During the study period, 173 patients had an IUC removed, and
were therefore eligible for enrollment in the protocol. The mean age
of participants was 60.4 years § 15.8, of which 56% were female, and
57% were Caucasian. The mean length of stay (LOS) was 7.9 §
7.2 days. The mean number of catheter days was 1.4 § 2.7. Forty-six
percent of the patients were admitted to the ICU, with the remaining
54% in either the neurologic and/or neurosurgical step-down units or
GPUs. One CAUTI was identiﬁed during the study protocol. All other
descriptive characteristics, stratiﬁed by all 3 times periods, are
included in Table 1.
IUC reinsertion rates decreased during the study period when
compared to the historical cohorts. A reinsertion rate of 16% was
noted for the study period compared to 21% and 27% (P = .02) in the
pre-pilot and 2019 cohorts, respectively. The mean number of catheter day’s was signiﬁcantly greater in the 2019 period (9.5 days) when
just compared to the pilot period (1.4 days) (P = .0002). In review of
all 3 times periods, the mean number of catheter day’s was signiﬁcantly lower during the protocol period (1.4 days) compared to the
pre-pilot (5.6 days) and 2019 (9.5 days) cohorts (P = .006). The absolute rates of CAUTIs differed between the 3 time periods with 4 of
235 (1.7%) in the 2019 cohort, 2 of 173 (1.2%) in the pre-pilot cohort
and 1/172 (0.6%) during the pilot, (Table 1).
On univariable analysis, LOS (OR 1.12, 95% CI 1.06-1.17, P <.0001),
and catheter hours (OR 1.01, 95% CI 1.00-1.01, P < .0001) were statistically signiﬁcant individual predictors of IUC reinsertion during the

Table 1
Comparison of patient characteristics who presented with or had an indwelling urinary catheter (IUC) placed and subsequently removed on participating units
Variable

Response

2019

Pre-pilot

Pilot

P-Value

Sex

Male
Female
Mean (SD)
white
black
Other and/or Unknown
Mean (SD)
ICU
Non−ICU
Mean (SD)
No
Yes
No
Yes
No
Yes
Mean (SD)
No
Yes
No
Yes

112 (47%)
127 (53%)
62 (14)
132 (55%)
81 (34%)
26 (10%)
30.4 (7.6)
96 (40%)
142 (60%)
7.5 (7.0)
131 (55%)
108 (45%)
192 (80%)
47 (20%)
209 (87%)
30 (13)
9.5 (62)
175 (73%)
64 (27%)
235 (98.3%)
4 (1.7%)

79 (45%)
96 (55%)
59 (14)
100 (57%)
52 (30%)
23 (13%)
29.1 (6.6)
85 (49%)
90 (51%)
8.1 (7.3)
104 (59%)
71 (41%)
146 (83%)
29 (17%)
162 (93%)
13 (7%)
5.6 (35)
139 (79%)
36 (21%)
173 (98.8%)
2 (1.2%)

77 (45%)
96 (55%)
60 (16)
99 (57%)
55 (32%)
19 (11%)
29.6 (7.9)
80 (46%)
93 (54%)
7.9 (7.2)
98 (56%)
75 (44%)
131 (76%)
42(24%)
161 (93 %)
12 (7%)
1.4 (2.7)
146 (84%)
27 (16%)
172 (99.4%)
1(0.6%)

.8

Age
Race

BMI
Admitting Unit
Length of Stay (D)
Hypertension
Diabetes
Use of alpha Blocker
Catheter D*
Catheter Reinsertion
CAUTI

Abbreviations: Catheter associated urinary tract infection (CAUTI), Standard Deviation (SD).
*Catheter days as deﬁned by the Centers for Disease Control and Prevention (CDC)’s National Healthcare Safety Network (NHSN).
y
Unable to determine statistical signiﬁcance due to low overall rates of CAUTIs.
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Table 2
Univariable and multivariable logistic regression results for predictors of Indwelling Urinary Catheter (IUC) reinsertion.
Univariate

Multivariate

Variable

Comparison

OR (CI)

P-Value

OR (CI)

P-Value

Sex
Race
Race
Race
Hypertension
Diabetes
Alpha Blocker
Age
Length of Stay (D)
Catheter D
Catheter H

Female vs Male
Non−white vs Other and/or Unknown
Non−white vs white
Other and/or Unknown vs white
Yes vs No
Yes vs no
Yes vs No

0.84 (0.37 - 1.91)
2.43 (0.17 - 34.25)
0.60 (0.19 - 1.88)
0.25 (0.020 - 3.13)
1.50 (0.66 - 3.42)
1.4 (0.56 - 3.45)
1.90 (0.48 - 7.54)
1.01 (0.96 - 1.03)
1.12 (1.06 - 1.17)
1.11 (0.97 - 1.26)
1.01 (1.00 - 1.01)

.7
1
.86
.6
.3
.3
.4
.4
<.0001
.1
<.0001

1.01 (1.005 − 1.015)

<.0001

Abbreviations: Odds Ratio (OR), Conﬁdence Interval (CI).

pilot. Only catheter hours were shown to be a predictor of IUC reinsertion on multivariable analysis (OR 1.01, 95% CI 1.00-1.01, P <
.0001) Table 2. Univariable and multivariable analysis for the remaining 2 time periods can be found in Supplementary File 1. On multivariate analysis, LOS was noted to be a statistically signiﬁcant predictor
of catheter reinsertion, (OR 1.25, 95% CI 1.17-1.33, P <.0001) in the
2019 cohort. Unlike the pilot cohort, race was also noted to be an
independent predictor of IUC reinsertion in the 2019 cohort. Non
−white patients were noted to have a lower odds of catheter reinsertion versus white patients, (OR 0.39, 95% CI 0.17-0.91, P = .02), Supplementary File 1.

DISCUSSION
This study describes our initial experience with the UCANP trial at
a large urban, tertiary health care center. Our pilot study provided
healthcare providers with a clear post-catheter removal protocol to
manage urinary retention and mitigate the reinsertion of IUCs. The
implementation of our protocol resulted in a signiﬁcant reduction in
the overall number of catheter days and rates of reinsertion when
compared to the historical cohorts. This ﬁnding has clinical relevance,
as it has been well reported that number of catheter days is a known
risk factor for the development of CAUTI.4,14,22-24 Previous investigations have noted that speciﬁc baseline patient characteristics, such as
age, sex and use of alpha-blockers, may result in higher rates of urinary retention following catheter removal.25 Therefore, the difference in rates of catheter days was likely not due to a variation in the
baseline characteristics of the patients, but rather due to the implementation of the protocol.
There was a 16% catheter reinsertion rate during the pilot period
versus 21% and 27% reinsertion rates during the pre-pilot and 2019
cohorts, respectively. These ﬁndings suggest that the protocol successfully decreased the rate of reinsertion. Given the small number of
CAUTIs among all cohorts, we are unable to comment on any potential signiﬁcant reductions as a result of the protocol. However, a
decrease in the incidence of CAUTI from 1.2% to 1.7% during the prepilot and 2019 time periods to 0.6% during the study was appreciated.
This outcome can be further investigated in a larger patient population if UCANP is implemented hospital or system wide.
On multivariable analysis, catheter hours were identiﬁed as the
only signiﬁcant predictor of catheter reinsertion, suggesting that prolonged periods with an IUC results in an increased likelihood of trial
of void failure. We also identiﬁed various risk factors pre-disposing
patients to catheter reinsertion in the historical cohorts. Most notably, race was identiﬁed as a risk factor in the 2019 cohort but not in
the pilot cohort. It remains unclear as to why this differed between
the 2 groups given that the pre-pilot cohort also did not demonstrate

this difference. Further investigation is warranted when the UCANP
is implemented on a larger scale.
Our investigation is not devoid of limitations. First, this was a
piloted protocol applied in highly selected units within a single institution, therefore resulting in a small number of patients. It could be
argued that orchestrating and ensuring protocol compliance is more
manageable given the smaller sample sizes and that the previously
mentioned beneﬁts may diminish when expanding to include entire
hospital or health system. However, previous investigations have
demonstrated the feasibility of implementing and coordinating large
scale efforts across multiple hospitals in reducing rates of CAUTI with
reported beneﬁt.17,20,21 Secondly, all units involved in this study specialized in the care of neurologic and neurosurgical patients. Given
that many of these patients had spinal cord injuries or other neurologic conditions resulting in higher rates of urinary retention and UTI,
it is possible that this patient population could have inﬂated or
diminished the beneﬁts of the protocol.26 Future investigations of the
protocol will likely require a more diverse patient population. Lastly,
this was a prospective quality improvement initiative, and we were
unable to account for any bias which could have potentially confounded our results, including which patients were deemed eligible
for catheter removal.
In conclusion, our ﬁndings demonstrate that UCANP is an effective
and feasible approach to decrease the rates of IUC reinsertion and
number of catheter days. Given the initial ﬁndings of this pilot study,
we plan to implement this protocol in a larger cohort of patients with
the aim of potentially capturing a reduction in CAUTIs.
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